Sign In
Buy SDGR
$14.93
-0.0100 (-0.0669%)
At Close: Jun 03, 2026
Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
05:02am, Monday, 23'rd Mar 2026
Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30am, Wednesday, 18'th Mar 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on March 14, 2026, the company granted (i) a non-statutory stock option to purchase 1,950 shares of the company's commo
Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
08:25am, Friday, 06'th Mar 2026
Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Citigroup Inc. Grows Stake in Schrodinger, Inc. $SDGR
04:20am, Friday, 06'th Mar 2026
Citigroup Inc. boosted its position in shares of Schrodinger, Inc. (NASDAQ: SDGR) by 122.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The inst
Schrödinger, Inc. (SDGR) Q4 2025 Earnings Call Transcript
08:17pm, Wednesday, 25'th Feb 2026
Schrödinger, Inc. (SDGR) Q4 2025 Earnings Call Transcript
Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results
04:05pm, Wednesday, 25'th Feb 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the fourth quarter and full-year ended December 31, 2025, and provided its 2026 outlook and 2028 fina
Schrödinger to Participate in Upcoming Investor Conferences
08:30am, Tuesday, 24'th Feb 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in the following conferences in March: TD Cowen 46th Annual Health Care Conference: Firesi
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30am, Wednesday, 18'th Feb 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on February 13, 2026, the company granted (i) non-statutory stock options to purchase 9,600 shares of the company's com
Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25
08:30am, Wednesday, 11'th Feb 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) will report its fourth quarter and full-year 2025 financial results on Wednesday, February 25, 2026, after the financial markets close. The
The Genesis Mission Has a 270-Day Timeline – And You’re Already Late
12:00am, Tuesday, 27'th Jan 2026
The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.
Critical Survey: Hims & Hers Health (NYSE:HIMS) versus Schrodinger (NASDAQ:SDGR)
01:15am, Thursday, 22'nd Jan 2026
Hims and Hers Health (NYSE: HIMS - Get Free Report) and Schrodinger (NASDAQ: SDGR - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses
Market Today: Banks, Big Tech, Biopharma and Energy Move on Policy and Deals
05:34pm, Monday, 12'th Jan 2026
Guru Stock PicksJerome Dodson has made the following transactions:Reduce in ORLY by 3%Sold out in BLDRAdd in NTRA by 2.49%New position in INSMTweedy Browne Inte
Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities
08:30am, Monday, 12'th Jan 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic priorities for 2026. The company is continuing t
Schrodinger to offer Eli Lilly's AI drug discovery platform on its software
07:04am, Friday, 09'th Jan 2026
Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, on its drug designing software.
Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign
07:00am, Friday, 09'th Jan 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced a collaboration with Lilly TuneLab™, a platform launched by Eli Lilly and Company (Lilly) designed to accelerate drug dis
